104 related articles for article (PubMed ID: 3121563)
1. Effect of doxorubicin on lipid peroxide levels in tissues of mice.
Sazuka Y; Yoshikawa K; Tanizawa H; Takino Y
Jpn J Cancer Res; 1987 Nov; 78(11):1281-6. PubMed ID: 3121563
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
Minotti G; Mancuso C; Frustaci A; Mordente A; Santini SA; Calafiore AM; Liberi G; Gentiloni N
J Clin Invest; 1996 Aug; 98(3):650-61. PubMed ID: 8698856
[TBL] [Abstract][Full Text] [Related]
3. The influence of doxorubicin and 4'-epi-doxorubicin on lipid peroxidation in mouse heart, lungs and liver. Part II.
Pierściński G; Drzewoski J; Nowak D
Pol J Pharmacol; 1994; 46(1-2):55-9. PubMed ID: 7981772
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
Mimnaugh EG; Gram TE; Trush MA
J Pharmacol Exp Ther; 1983 Sep; 226(3):806-16. PubMed ID: 6411900
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection.
Abd-Allah AR; Al-Majed AA; Mostafa AM; Al-Shabanah OA; Din AG; Nagi MN
J Biochem Mol Toxicol; 2002; 16(5):254-9. PubMed ID: 12439867
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
Khan M; Shobha JC; Mohan IK; Naidu MU; Sundaram C; Singh S; Kuppusamy P; Kutala VK
Phytother Res; 2005 Dec; 19(12):1030-7. PubMed ID: 16372368
[TBL] [Abstract][Full Text] [Related]
7. [Effects of anthracycline drugs (aclarubicin, daunorubicin, doxorubicin, epirubicin, pirarubicin) on mouse acute toxicity and rat liver microsomal lipid peroxidation].
Shinozawa S; Gomita Y; Araki Y
Gan To Kagaku Ryoho; 1992 Jun; 19(6):805-9. PubMed ID: 1605657
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
[TBL] [Abstract][Full Text] [Related]
10. The role of biotransformation in anthracycline-induced cardiotoxicity in mice.
de Jong J; Schoofs PR; Snabilié AM; Bast A; van der Vijgh WJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1312-20. PubMed ID: 8371139
[TBL] [Abstract][Full Text] [Related]
11. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
13. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
15. Conjugated dienes in selected organs of mice treated with doxorubicin and 4'-epi-doxorubicin. Part I.
Drzewoski J; Pierściński G; Nowak D
Pol J Pharmacol; 1994; 46(1-2):51-4. PubMed ID: 7981771
[TBL] [Abstract][Full Text] [Related]
16. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
17. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.
Dubois V; Dasnois L; Lebtahi K; Collot F; Heylen N; Havaux N; Fernandez AM; Lobl TJ; Oliyai C; Nieder M; Shochat D; Yarranton GT; Trouet A
Cancer Res; 2002 Apr; 62(8):2327-31. PubMed ID: 11956091
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of rat heart microsomal lipid peroxidation following doxorubicin treatment in vivo.
Mimnaugh EG; Trush MA; Gram TE
Cancer Treat Rep; 1983; 67(7-8):731-3. PubMed ID: 6871890
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation.
Kharasch ED; Novak RF
J Pharmacol Exp Ther; 1983 Aug; 226(2):500-6. PubMed ID: 6875860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
